However, the ATX-LPA axis has emerged as a novel regulator of multiple molecular pathways and has been strongly implicated in a variety of physiological and pathological processes, including pulmonary fibrosis [48, 49], neuropathic pain [50], cardiovascular disease [51], and tumor progression [52–56]. This evidence concerns the gene LPA and cardiovascular disorder.